Zim Laboratories Ltd
NSE:ZIMLAB
Zim Laboratories Ltd
NSE:ZIMLAB
Price:
60.76
INR
-10.22%
Market Cap:
₹3.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zim Laboratories Ltd
NSE:ZIMLAB
|
IN |
|
H
|
Hindustan Composites Ltd
NSE:HINDCOMPOS
|
IN |
|
Archi Indonesia Tbk PT
IDX:ARCI
|
ID |
|
L
|
Larsen & Toubro Ltd
OTC:LTOUF
|
IN |
|
Rattanindia Enterprises Ltd
NSE:RTNINDIA
|
IN |
|
Feintool International Holding AG
SIX:FTON
|
CH |
|
Mckesson Corp
NYSE:MCK
|
US |
|
MIRC Electronics Ltd
NSE:MIRCELECTR
|
IN |
|
Sequans Communications SA
NYSE:SQNS
|
FR |
|
K
|
Konica Minolta Inc
OTC:KNCAY
|
JP |
|
M
|
Mr Blue Corp
KOSDAQ:207760
|
KR |
|
Fujian Sanmu Group Co Ltd
SZSE:000632
|
CN |
|
C
|
CyberAgent Inc
OTC:CYAGF
|
JP |
|
O
|
Oriental Times Media Corp
SZSE:002175
|
CN |
Relative Value
The Relative Value of one
ZIMLAB
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 60.76 INR,
Zim Laboratories Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ZIMLAB Relative Value
HIDDEN
Multiples Across Competitors
ZIMLAB Competitors Multiples
Zim Laboratories Ltd Competitors
Zim Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Zim Laboratories Ltd
NSE:ZIMLAB
|
3B INR | 0.8 | 42.4 | 9.8 | 21.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.2 | 41.7 | 28.1 | 30 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.5 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.3 | 6.9 | 8.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
